About etelcalcetide
Calcimimetic agent
Used for
- Treats secondary hyperparathyroidism in adults with chronic kidney disease receiving hemodialysis.
Usual adult dose
Start 5 mg intravenously three times weekly after hemodialysis; adjust every four weeks, up to 15 mg three times weekly.
Common side effects
- Low blood calcium
- Nausea
- Vomiting
- Diarrhea
Important warnings
- Can cause dangerously low calcium; monitor blood calcium before treatment and during dose changes.
- Do not start if blood calcium is below normal.
- May cause seizures, muscle spasms, or abnormal heart rhythm from low calcium.
- Avoid use with other calcimimetics such as cinacalcet.
Pregnancy
Human pregnancy information is limited; use only when clearly needed and after weighing potential risks.
Breastfeeding
It is unknown whether etelcalcetide passes into breast milk; consider treatment needs and potential infant effects.
Interactions
- Other calcimimetics can increase the risk of low blood calcium.
- Drugs that lower blood calcium may increase the risk of hypocalcemia.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.